Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet M Allen

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Diabetes Technology & Therapeutics|March 1, 2024
Lived Experience of Fully Closed-Loop Insulin Delivery in Adults with Type 1 DiabetesRama Lakshman, Sara Hartnell, Julia Ware, et al.
The Journal of Biological Chemistry|June 2, 2007
alphavbeta5 integrin sustains growth of human pre-B cells through an RGD-independent interaction with a basic domain of the CD23 proteinGillian Borland, Adrienne L Edkins, Mridu Acharya, et al.
Diabetes Care|September 13, 2013
Feasibility of closed-loop insulin delivery in type 2 diabetes: a randomized controlled studyKavita Kumareswaran, Hood Thabit, Lalantha Leelarathna, et al.
Diabetes Care|January 8, 2016
Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical TrialMartin Tauschmann, Janet M Allen, Malgorzata E Wilinska, et al.
Diabetes Technology & Therapeutics|October 12, 2023
CamAPS FX Hybrid Closed-Loop with Ultra-Rapid Lispro Compared with Standard Lispro in Adults with Type 1 Diabetes: A Double-Blind, Randomized, Crossover StudyMunachiso Nwokolo, Rama Lakshman, Sara Hartnell, et al.
BMJ Open Diabetes Research & Care|December 3, 2014
Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parentsKatharine D Barnard, Tim Wysocki, Janet M Allen, et al.
Diabetes Technology & Therapeutics|February 6, 2019
Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative StudyJulia Lawton, Maxine Blackburn, David Rankin, et al.
Diabetes Technology & Therapeutics|March 2, 2011
Automated overnight closed-loop glucose control in young children with type 1 diabetesDaniela Elleri, Janet M Allen, Marianna Nodale, et al.
Pediatric Diabetes|July 24, 2012
Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetesDaniela Elleri, Janet M Allen, Martina Biagioni, et al.
Diabetes Technology & Therapeutics|March 7, 2023
Hybrid Closed-Loop with Faster Insulin Aspart Compared with Standard Insulin Aspart in Very Young Children with Type 1 Diabetes: A Double-Blind, Multicenter, Randomized, Crossover StudyJulia Ware, Janet M Allen, Charlotte K Boughton, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Diabetes Technology & Therapeutics|March 1, 2024
Lived Experience of Fully Closed-Loop Insulin Delivery in Adults with Type 1 DiabetesRama Lakshman, Sara Hartnell, Julia Ware, et al.
The Journal of Biological Chemistry|June 2, 2007
alphavbeta5 integrin sustains growth of human pre-B cells through an RGD-independent interaction with a basic domain of the CD23 proteinGillian Borland, Adrienne L Edkins, Mridu Acharya, et al.
Diabetes Care|September 13, 2013
Feasibility of closed-loop insulin delivery in type 2 diabetes: a randomized controlled studyKavita Kumareswaran, Hood Thabit, Lalantha Leelarathna, et al.
Diabetes Care|January 8, 2016
Day-and-Night Hybrid Closed-Loop Insulin Delivery in Adolescents With Type 1 Diabetes: A Free-Living, Randomized Clinical TrialMartin Tauschmann, Janet M Allen, Malgorzata E Wilinska, et al.
Diabetes Technology & Therapeutics|October 12, 2023
CamAPS FX Hybrid Closed-Loop with Ultra-Rapid Lispro Compared with Standard Lispro in Adults with Type 1 Diabetes: A Double-Blind, Randomized, Crossover StudyMunachiso Nwokolo, Rama Lakshman, Sara Hartnell, et al.
BMJ Open Diabetes Research & Care|December 3, 2014
Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parentsKatharine D Barnard, Tim Wysocki, Janet M Allen, et al.
Diabetes Technology & Therapeutics|February 6, 2019
Participants' Experiences of, and Views About, Daytime Use of a Day-and-Night Hybrid Closed-Loop System in Real Life Settings: Longitudinal Qualitative StudyJulia Lawton, Maxine Blackburn, David Rankin, et al.
Diabetes Technology & Therapeutics|March 2, 2011
Automated overnight closed-loop glucose control in young children with type 1 diabetesDaniela Elleri, Janet M Allen, Marianna Nodale, et al.
Pediatric Diabetes|July 24, 2012
Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetesDaniela Elleri, Janet M Allen, Martina Biagioni, et al.
Diabetes Technology & Therapeutics|March 7, 2023
Hybrid Closed-Loop with Faster Insulin Aspart Compared with Standard Insulin Aspart in Very Young Children with Type 1 Diabetes: A Double-Blind, Multicenter, Randomized, Crossover StudyJulia Ware, Janet M Allen, Charlotte K Boughton, et al.
Pageof 9